ANIK Anika Therapeutics Inc

USD 17.84 +0.56 ( +3.24%)
Icon

Anika Therapeutics Inc (ANIK) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 17.84

+0.56 (+3.24%)

USD 0.25B

0.05M

USD 33.00(+84.98%)

USD 35.50 (+98.99%)

Icon

ANIK

Anika Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 17.84
+0.56 ( +3.24%)

Anika Therapeutics Inc (ANIK) Stock Forecast

USD 33.00
(+84.98%)

Based on the Anika Therapeutics Inc stock forecast from 1 analysts, the average analyst target price for Anika Therapeutics Inc is USD 33.00 over the next 12 months. Anika Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Anika Therapeutics Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Anika Therapeutics Inc’s stock price was USD 17.84. Anika Therapeutics Inc’s stock price has changed by +6.57% over the past week, +10.19% over the past month and -22.77% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...